when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Immunology · news · pharmadog

← back to Immunology

News · Immunology

412 stories

Jun 30, 26Beeline ups its Series A round for immune drug workbiopharma dive

Jun 30, 26Beeline adds $126M to Bain-backed immunology pipeline from Bristol Myersendpoints

Jun 29, 26NEJM retracts pivotal data for Amgen's Tavneosendpoints

Jun 29, 2610 clinical trials to watch in the second half of 2026biopharma dive

Jun 26, 26La Ceiba Foods Latin Market Inc. Recalls Cottage Cheese Products Because of Possible Health Riskfda recalls

Jun 20, 26Opinion: STAT readers debate blue zones, open-access publishing fees, and morestat

Jun 18, 26Moderna flu vaccine wins unanimous support from FDA panelbiopharma dive

Jun 18, 26Biogen adds more immune drugs in $1B buyout of secretive startup RayTherabiopharma dive

Jun 17, 26Jazz zeroes in on next-gen T cell engagers with AbCellera dealbiopharma dive

Jun 16, 26Lilly buys non-opioid pain drugmaker 4Ebiopharma dive

Jun 16, 26FDA staff scrutinizes evidence supporting Moderna’s flu vaccinebiopharma dive

Jun 16, 26The U.S. infant mortality rate fell to an all-time low, though it still trails other similar nationsstat

Jun 16, 26How supplement use changed over decadesstat

Jun 16, 26UCSF spinout Kopra Bio raises $9.1M to test virus therapy in brain cancerendpoints

Jun 15, 26J&J multiple myeloma drug gains edge in earlier stage diseasebiopharma dive

Jun 15, 26Celiac disease is entering a new era of therapeutic innovationbiopharma dive

Jun 11, 26J&J looks to widen Imaavy’s use; $300M backs rare disease drug launchbiopharma dive

Jun 11, 26Takeda’s $4B TYK2 drug tops Bristol Myers’ Sotyktu in head-to-head testbiopharma dive

Jun 10, 26Ethyreal starts up with $101M and takes aim at a pair of immune diseasesbiopharma dive

Jun 10, 26Sanofi stops immune drug trial in latest research setbackbiopharma dive

Jun 10, 26STAT+: Hope for Kendall Square’s lab marketstat

Jun 10, 26AstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicinebiopharma dive

Jun 10, 26Ethyreal lands $101M to treat both Graves' and thyroid eye diseaseendpoints

Jun 9, 26Stealthy startup Treeline plans a reverse mergerbiopharma dive

Jun 8, 26Roche stakes $700M on Nurix’s protein-degrading drugbiopharma dive

Jun 8, 26J&J to acquire Firefly, maker of ‘degrader’ antibody drugs, for $1Bbiopharma dive

Jun 8, 26Nurix to work with Roche on BTK degrader in pact worth up to $2.3Bendpoints

Jun 5, 26Senior NIH official pushes MAHA strategy to skeptical ADA audiencestat

Jun 4, 26Otsuka touts new IgAN evidence as it seeks full approval for Voyxactendpoints

Jun 4, 26STAT+: Otsuka kidney drug slowed loss of function, but less than expected, in late-stage trialstat

← prevpage 8 of 14next →